Kanlayanee Sawanyawisuth Selected Research

Kanlayanee Sawanyawisuth Research Topics

Disease

38	Cholangiocarcinoma 05/2022 - 01/2007
24	Neoplasms (Cancer) 05/2022 - 01/2007
10	Neoplasm Metastasis (Metastasis) 02/2022 - 03/2008
2	Bile Duct Neoplasms (Bile Duct Cancer) 01/2021 - 12/2018
2	Meningitis 12/2020 - 10/2010
2	Headache (Headaches) 12/2020 - 10/2008
2	Carcinogenesis 01/2020 - 11/2019
1	Hyperglycemia 01/2022
1	Diabetes Mellitus 01/2022
1	Asthma (Bronchial Asthma) 04/2020
1	Necrosis 07/2018
1	Eosinophilia 11/2010
1	Angiostrongyliasis 11/2010
1	Tuberculosis (Tuberculoses) 07/2009
1	Inflammation (Inflammations) 10/2008
1	Retinitis 10/2008
1	Optic Neuritis (Retrobulbar Neuritis) 10/2008

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 02/2018 - 06/2014
4	Pharmaceutical PreparationsIBA 12/2021 - 01/2007
4	Proteins (Proteins, Gene)FDA Link 04/2020 - 03/2008
4	Polysaccharides (Glycans)IBA 01/2020 - 02/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2017
3	Fluorouracil (Carac)FDA LinkGeneric 12/2021 - 07/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020 - 10/2008
3	Methionine (L-Methionine)FDA Link 01/2019 - 01/2012
3	Cyclophilin AIBA 02/2015 - 08/2011
2	CalciumIBA 02/2022 - 01/2016
2	Protein Isoforms (Isoforms)IBA 04/2021 - 11/2018
2	Phosphotransferases (Kinase)IBA 01/2021 - 09/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 05/2019
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2012
2	EnzymesIBA 01/2020 - 01/2007
2	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 01/2019 - 01/2012
2	VimentinIBA 11/2018 - 01/2017
2	Small Interfering RNA (siRNA)IBA 01/2016 - 03/2008
2	Tumor Biomarkers (Tumor Markers)IBA 06/2014 - 03/2012
2	methionine aminopeptidase 2IBA 01/2012 - 01/2007
1	N- (2,6- diethylphenyl)- 1- methyl- 8- ((4- ((1- methylpiperidin- 4- yl)carbamoyl)- 2- (trifluoromethoxy)phenyl)amino)- 4,5- dihydro- 1H- pyrazolo(4,3- h)quinazoline- 3- carboxamideIBA 05/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2022
1	Annexin A1IBA 02/2022
1	Carrier Proteins (Binding Protein)IBA 02/2022
1	Cyclin AIBA 01/2022
1	siomycin AIBA 12/2021
1	Thymidylate SynthaseIBA 12/2021
1	AcidsIBA 07/2021
1	2- (4- morpholinoanilino)- 6- cyclohexylaminopurineIBA 01/2021
1	Chromomycin A3IBA 04/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2020
1	Vicia lectinsIBA 01/2020
1	LectinsIBA 01/2020
1	FucoseIBA 11/2019
1	Epidermal Growth Factor (EGF)IBA 11/2019
1	alvocidib (flavopiridol)IBA 05/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2019
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2019
1	Estrogens (Estrogen)FDA Link 12/2018
1	Estrogen ReceptorsIBA 12/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	Mannose (D-Mannose)IBA 10/2018
1	Mannose-Binding LectinsIBA 10/2018
1	AgglutininsIBA 10/2018
1	ArtesunateIBA 07/2018
1	Caspase 3 (Caspase-3)IBA 07/2018
1	Chloroquine (Aralen)FDA LinkGeneric 07/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2018
1	sophora japonica agglutininIBA 02/2018
1	AcetylgalactosamineIBA 02/2018
1	Lactate Dehydrogenase 5IBA 05/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	antineoplaston A10 (A 10)IBA 09/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Surface Antigens (Surface Antigen)IBA 01/2016
1	Antiparasitic Agents (Antiparasitics)IBA 11/2014
1	Mebendazole (Anti-Worm)FDA Link 11/2014
1	ThymosinIBA 09/2013
1	CarbohydratesIBA 03/2012
1	AntigensIBA 03/2012
1	fumagillinIBA 01/2012
1	Peptide Hydrolases (Proteases)FDA Link 01/2012
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2012
1	cepharanthineIBA 01/2012
1	Indicators and Reagents (Reagents)IBA 11/2010
1	Tuberculin (PPD)IBA 07/2009
1	Galectin 3 (LGALS3)IBA 03/2008
1	Galectins (Galectin)IBA 03/2008
1	Biological ProductsIBA 03/2008

Therapy/Procedure

6	Therapeutics 12/2020 - 03/2008
4	Drug Therapy (Chemotherapy) 01/2019 - 07/2016
1	Radiotherapy 09/2014